Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

9.98
+0.06000.60%
Post-market: 10.270.2900+2.91%19:53 EDT
Volume:1.73M
Turnover:17.04M
Market Cap:858.75M
PE:-2.59
High:10.03
Open:9.87
Low:9.49
Close:9.92
Loading ...

Syndax exec buys $105.8K, director buys $91.1K in common stock

TIPRANKS
·
20 May

Nicholas A.J. Botwood, Head of R&D, CMO, Reports Acquisition of Common Shares of Syndax Pharmaceuticals Inc

Reuters
·
20 May

Director Keith Katkin Reports Acquisition of Common Shares in Syndax Pharmaceuticals Inc

Reuters
·
20 May

Syndax Pharmaceuticals Appoints New Head of R&D

TIPRANKS
·
17 May

Syndax Pharmaceuticals Files Initial Beneficial Ownership Statement for Nicholas A.J. Botwood, Head of R&D, CMO

Reuters
·
17 May

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as New Head of R&D and Chief Medical Officer

Reuters
·
17 May

Syndax Pharmaceuticals to Present Clinical Data on Revuforj® and Niktimvo™ at the European Hematology Association Annual Congress

Reuters
·
14 May

Syndax Pharmaceuticals Appoints Nicholas Botwood Chief Medical Officer

MT Newswires Live
·
13 May

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer, Succeeding Dr. Neil Gallagher

Reuters
·
13 May

Press Release: Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

Dow Jones
·
13 May

Syndax Pharmaceuticals Price Target Maintained With a $32.00/Share by Guggenheim

Dow Jones
·
06 May

Stock Track | Syndax Pharmaceuticals Plummets 5.60% Following Wider Q1 Loss Despite Beating Expectations

Stock Track
·
06 May

Syndax price target raised to $17 from $16 at Scotiabank

TIPRANKS
·
06 May

Syndax Pharmaceuticals (SNDX) Gets a Buy from Barclays

TIPRANKS
·
06 May

Syndax price target raised to $26 from $25 at BofA

TIPRANKS
·
06 May

Promising Growth and Strategic Positioning Drive Buy Rating for Syndax Pharmaceuticals

TIPRANKS
·
06 May

Syndax Pharmaceuticals Q1 Loss Widens

MT Newswires Live
·
06 May

TD Cowen Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
06 May

Syndax Pharmaceuticals Reports Strong Q1 2025 Results

TIPRANKS
·
06 May

Syndax Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May